Terms: = Thyroid cancer AND TBL1XR1, C21, 79718, TBLR1, IRA1, FLJ12894, DC42
6 results:
1. TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.
Pray BA; Youssef Y; Alinari L
Exp Hematol; 2022 Dec; 116():18-25. PubMed ID: 36206873
[TBL] [Abstract] [Full Text] [Related]
2. Novel
Moody S; Thompson JS; Chuang SS; Liu H; Raderer M; Vassiliou G; Wlodarska I; Wu F; Cogliatti S; Robson A; Ashton-Key M; Bi Y; Goodlad J; Du MQ
Haematologica; 2018 Aug; 103(8):1329-1336. PubMed ID: 29674500
[TBL] [Abstract] [Full Text] [Related]
3. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract] [Full Text] [Related]
4. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
Klotz RK; Müller-Holzner E; Fessler S; Reimer DU; Zervomanolakis I; Seeber B; Mattle V; Wildt L
Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
[TBL] [Abstract] [Full Text] [Related]
5. The thyroperoxidase doublet is not produced by alternative splicing.
Cetani F; Costagliola S; Tonacchera M; Panneels V; Vassart G; Ludgate M
Mol Cell Endocrinol; 1995 Dec; 115(2):125-32. PubMed ID: 8824887
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of aromatase with CGS 16949A in postmenopausal women.
Santen RJ; Demers LM; Adlercreutz H; Harvey H; Santner S; Sanders S; Lipton A
J Clin Endocrinol Metab; 1989 Jan; 68(1):99-106. PubMed ID: 2521224
[TBL] [Abstract] [Full Text] [Related]
